Structure based on 5t8f | Ideal structure |
|
Name: 2-methyl-2-(4-{2-[3-methyl-1-(propan-2-yl)-1h-1,2,4-triazol-5-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-1h-pyrazol-1-yl)propanamide |
Formula: C24 H28 N8 O2 |
Weight: 460.532 |
SMILES: "CC(C)n1nc(C)nc1c2cn3CCOc4cc(ccc4c3n2)c5cnn(c5)C(C)(C)C(N)=O" |
Spacial conformation based on PDB
5t8f. Also present on 8exl |
RESIDUE 799 62
CONECT C2 3 C4 N1 O3
CONECT C4 4 C2 C5 C6 N7
CONECT C5 4 C4 H1 H2 H3
CONECT C6 4 C4 H4 H5 H6
CONECT C8 3 N7 C9 H7
CONECT C12 3 C9 C13 C25
CONECT C16 4 C17 O15 H8 H9
CONECT C17 4 C16 N18 H10 H11
CONECT C19 3 N18 C20 H12
CONECT C23 3 C24 C14 C22
CONECT C24 3 C23 C25 H13
CONECT C32 4 C33 C34 N31 H14
CONECT C33 4 C32 H15 H16 H17
CONECT C34 4 C32 H18 H19 H20
CONECT N1 3 C2 H21 H22
CONECT O3 1 C2
CONECT N7 3 C4 C8 N11
CONECT C9 3 C8 C12 C10
CONECT C10 3 C9 N11 H23
CONECT N11 2 N7 C10
CONECT C13 3 C12 C14 H24
CONECT C14 3 C23 C13 O15
CONECT O15 2 C16 C14
CONECT N18 3 C17 C19 C22
CONECT C20 3 C19 N21 C26
CONECT N21 2 C20 C22
CONECT C22 3 C23 N18 N21
CONECT C25 3 C12 C24 H25
CONECT C26 3 C20 N27 N31
CONECT N27 2 C26 C28
CONECT C28 3 N27 C29 N30
CONECT C29 4 C28 H26 H27 H28
CONECT N30 2 C28 N31
CONECT N31 3 C32 C26 N30
CONECT H1 1 C5
CONECT H2 1 C5
CONECT H3 1 C5
CONECT H4 1 C6
CONECT H5 1 C6
CONECT H6 1 C6
CONECT H7 1 C8
CONECT H8 1 C16
CONECT H9 1 C16
CONECT H10 1 C17
CONECT H11 1 C17
CONECT H12 1 C19
CONECT H13 1 C24
CONECT H14 1 C32
CONECT H15 1 C33
CONECT H16 1 C33
CONECT H17 1 C33
CONECT H18 1 C34
CONECT H19 1 C34
CONECT H20 1 C34
CONECT H21 1 N1
CONECT H22 1 N1
CONECT H23 1 C10
CONECT H24 1 C13
CONECT H25 1 C25
CONECT H26 1 C29
CONECT H27 1 C29
CONECT H28 1 C29
END
HET 799 62
HETSYN 799 taselisib
HETNAM 799 2-methyl-2-(4-{2-[3-methyl-1-(propan-2-yl)-1H-1,2,4-tri
HETNAM 2 799 azol-5-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9
HETNAM 3 799 -yl}-1H-pyrazol-1-yl)propanamide
FORMUL 799 C24 H28 N8 O2